Franck E. Nicolini

5.0k citations
65 papers · 1.7k · 1 hit paper · h-index 19

Impact in

  • Hematology top 0.5%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Chronic Myeloid Leukemia Treatments 60
    • Acute Myeloid Leukemia Research 6
    • Chronic Lymphocytic Leukemia Research 48
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 5

Franck E. Nicolini

60 papers receiving 1.6k citations

Franck E. Nicolini's Hit Papers

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION) 2011 · 444 citations
4440+5+10Years since publication100200300400

Peers

Franck E. Nicolini
Comparison fields: 5 of 59
  • Hematology 1.5k
  • Genetics 999
  • Rheumatology 584
  • Oncology 219
  • Public Health, Environmental and Occupational Health 165
Replace Manuel Ayala with:
Manuel Ayala Mexico
Gabriele Gugliotta Italy
Jiří Mayer Czechia
Pierre Laneuville Canada
Elias Jabbour United States
Bettina Gisslinger Austria
Tanja Lahaye Germany
Jean‐Luc Laï France
Niove E. Jordanides United Kingdom
Enrico Montefusco Italy
Franck E. Nicolini relative to Manuel Ayala Mexico Manuel Ayala's profile →
Citations per field
00.5×3.8×
Manuel Ayala · 1×
Citations per year

Countries citing papers authored by Franck E. Nicolini

Since Specialization
Citations

This map shows the geographic impact of Franck E. Nicolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck E. Nicolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck E. Nicolini more than expected).

Fields of papers citing papers by Franck E. Nicolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck E. Nicolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck E. Nicolini. The network helps show where Franck E. Nicolini may publish in the future.

Co-authors

The 25 scholars most cited alongside Franck E. Nicolini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Franck E. Nicolini Line = papers co-authored together Franck E. Nicolini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
Hit paper breakdown →
2011444
2 2013129
3 2009101
4 201899
5 201291
6 201782
7 201367
8 200751
9 201148
10 201339
11 201734
12 201533
13 200932
14 201532
15 201831
16 201230
17 202030
18 200929
19 202128
20 201418

About Franck E. Nicolini

Franck E. Nicolini is a scholar working on Hematology, Genetics, Rheumatology, Public Health, Environmental and Occupational Health and Oncology, having authored 65 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (60 papers), Chronic Lymphocytic Leukemia Research (48 papers), Eosinophilic Disorders and Syndromes (15 papers), Acute Lymphoblastic Leukemia research (13 papers), Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), HER2/EGFR in Cancer Research (5 papers) and Click Chemistry and Applications (4 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (999 citations), Rheumatology (584 citations), Oncology (219 citations) and Public Health, Environmental and Occupational Health (165 citations). Franck E. Nicolini has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Jörge E. Cortes, Hagop M. Kantarjian, Andreas Hochhaus, Dong‐Wook Kim, Michele Baccarani, Giovanni Martinelli, Charles Chuah, Jeffrey H. Lipton, Jorge Milone and Tadeusz Robak. Their work appears in journals such as Blood, Journal of Clinical Oncology, Experimental Hematology, HemaSphere and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact